麻豆传媒网站

Part of the largest CIHR-led cancer prevention investment, 麻豆传媒网站 researchers will develop approaches to reduce cancer risk and improve early detection听

Four 麻豆传媒网站 researchers have received $7.9 million听total in funding from the Canadian Institutes of Health Research (CIHR)听and partners through the听Bringing Biology to Cancer Prevention Team Grants program, by the Honourable Marjorie Michel, Canada's Minister of Health.听

Over $41 million in听funding was announced to support 19 teams that will work over the next five years to develop and share new approaches that support cancer prevention, reduce cancer risk, and improve early detection for some of the most commonly diagnosed cancers in Canada and the world.听

The funding is led by CIHR in partnership with the Terry Fox Research Institute, the Canadian Cancer Society, the Japan Agency for Medical Research and Development, the Cancer Research Society, and BioCanRx. It is the single largest CIHR-led investment in cancer prevention research to date.听

Cancer is the leading cause of death in Canada, and it is estimated to cost the health care system, patients, and families nearly $37.7 billion every year. Up to 40% of cancer cases could be prevented through changes in lifestyle and environmental factors, including prevention strategies and early detection.听

鈥淩esearch can save lives and reduce the burden of cancer. Scientists, clinicians, trainees, survivors, families, cancer advocates, and others all have a role to play. When one of us succeeds, we all benefit from that success,鈥� said Honourable Marjorie Michel. 鈥淭oday鈥檚 announcement is a great example of how by working together across countries, and across disciplines, we can build a stronger, more resilient, and healthier Canada.鈥�听

听
Recipients of 麻豆传媒网站-led projects:听
听
Mark Basik, Professor, Department of Oncology and Surgery; Full Member, 麻豆传媒网站 Centre for Translational Research in Cancer; Senior Investigator, Lady Davis Institute for Medical Research at the Jewish General Hospital听
Advancing Risk Stratification in Young Women at High Risk for Breast Cancer听
CIHR funding: $999,957 over 5 years听
Canadian Cancer Society funding: $1,000,000 over 5 years听
听

Maziar Divangahi 鈥� Professor, Department of Medicine; Strauss Chair in Respiratory Diseases, Principal Scientist; Research Institute of the 麻豆传媒网站 Health Centre 听
Unlocking the Power of Trained Immunity in Cancer听
CIHR funding:听$1,500,000 over 5 years 听
BioCanRx funding: $500,000 over 5 years听
听

Luke McCaffrey, Associate Professor, Department of Oncology; Researcher,听Rosalind and Morris Goodman Cancer Centre 听
Decoding Breast Cancer: How Intrinsic Factors and Distinct Tissue Microenvironments Collaboratively Drive Breast Cancer Initiation听
CIHR funding: $1,000,000 over 5 years听
Canadian Cancer Society funding: $1,000,000 over 5 years听

听
Michael Pollak, Alexander Goldfarb Research Chair in Medical Oncology; Professor, Departments of Oncology, Pharmacology听and Medicine; and Principal Investigator, Lady Davis Institute for Medical Research at the Jewish General Hospital听
Incretin-mimetic drugs for cancer prevention: Mechanisms and clinical potential 听
Terry Fox Research Institute funding: $1,975,000 over 5 years听

听

听